Skip to main content
. 2024 Aug 3;8(1):e002680. doi: 10.1136/bmjpo-2024-002680

Table 3. Risk factors for severe diabetic ketoacidosis (DKA) at diagnosis of T1D.

Variables Severe DKA Mild/no DKA Univariate Multivariate
n % n % OR 95% CI P value OR 95% CI P value
Age at diagnosis (years.) 2.31 1.59 to 3.36 <0.001 2.50 1.24 to 5.06 0.010
 <10 104 51.7 97 48.3
 ≥10 90 31.7 194 68.3
Sex 1.50 1.04 to 2.17 0.028 1.52 0.77 to 3.00 0.226
 Girl 103 45.2 125 54.8
 Boy 91 35.4 166 64.6
HbA1c (mmol/mol %) 5.91 3.85 to 9.09 <0.001 2.79 1.26 to 6.17 0.012
 > 86 (>10%) 158 56 124 44
 ≤ 86 (≤10%) 36 17.7 167 82.3
Plasma glucose (mmol/L) 4.78 3.22 to 7.09 <0.001 2.18 1.01 to 4.69 0.047
 ≥ 22.2 138 58.2 99 41.8
 < 22.2 56 22.6 192 77.4
C-peptide (pmol/L) 2.14 1.15 to 4.00 0.016 1.27 0.63 to 2.59 0.503
 <200 36 46.2 42 53.8
 ≥200 28 28.6 70 71.4
Autoimmune T1D, n (%) 1.45 0.62 to 3.47 0.387
 Positive 30 39.0 47 61.0
 Negative 11 30.6 25 69.4
Appraisal interval (days) 1.13 0.79 to 1.63 0.504
 >12 106 41.4 150 58.6
 ≤12 88 38.4 141 61.6
Total diagnosis interval (days) 1.00 0.70 to 1.44 1.000
 >18 104 40 156 60
 ≤18 90 40 135 60
Family history of T1D 0.97 0.54 to 1.73 0.911
 Positive (familial T1D) 24 39.3 37 60.7
 Negative (sporadic T1D) 170 40.1 254 59.9

HbA1c (mmol/mol, SI units); plasma glucose (mmol/L).

Severe DKA: DKA with confirmed severe acidosis or from hospital records during admission; autoimmune T1D: autoantibody-positive diabetes; appraisal interval: time between onset of symptoms and decision to seek medical help; total diagnosis interval: time between onset of symptoms and treatment initiation; OR (95% CI): OR with 95% CI of independent risk factors for severe DKA and the values of p indicate the significance of risk association. A value of p<0.05 is statistically significant.

C-peptideconnecting peptideT1Dtype 1 diabetes